New York, New York, United States The main department of described VC is located in the New York. The venture was found in North America in United States.
Besides them, we counted 1 critical employee of this fund in our database.
When the investment is from Emerald Development Managers the average startup value is 10-50 millions dollars. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Health Care, Biotechnology. The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight DriverUp, Cyware Labs, Vixiar Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Emerald Development Managers, startups are often financed by TEDCO, TCP Venture Capital, Robin Hood Ventures. The meaningful sponsors for the fund in investment in the same round are Robin Hood Ventures, RRE Ventures, Great Road Holdings. In the next rounds fund is usually obtained by The Toro Company, SF Capital Group, Robin Hood Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alfa Framtak | Gullbringusysla, Iceland, Reykjavík |
| Archer Daniels Midland Company | Chicago, Illinois, United States |
| Boldcap Ventures | New York, New York, United States |
| Bsquare | Bellevue, United States, Washington |
| FastForward | Area A, Palestinian Territory, West Bank |
| Green Arrow Capital | Italy, Lombardy, Milan |
| Hangzhou Maikasha | China, Hangzhou, Zhejiang |
| Hepalink | China, Guangdong, Shenzhen |
| Listwin Ventures | - |
| Locojoy | Beijing, Beijing, China |
| Nex Cubed Digital Health | California, San Diego, United States |
| Prime Block Capital | - |
| Sanlam | Gauteng, Johannesburg, South Africa |
| Social Ventures Australia | Australia, New South Wales, Sydney |
| The March Fund | China, Hong Kong, Hong Kong Island |
| Topcon Corp. | Japan, Tokyo |
| University of Antwerp | Antwerp, Antwerpen, Belgium |
| Votorantim Novos Negocios | Brazil, São Paulo, Sao Paulo |
| Weimob | China, Shanghai |
| Zhoutong Touzi | Baoshan, China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Proscia | $9M | 11 Jan 2024 | Philadelphia, Pennsylvania, United States | ||
ETCH | $7M | 25 Jul 2023 | Chevy Chase, Maryland, United States | ||
Cyware | $30M | 29 Jun 2023 | New York, New York, United States | ||
Transcend Therapeutics | $40M | 23 Feb 2023 | Waltham, Massachusetts, United States | ||
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
Evolved By Nature | $120M | 28 Jun 2022 | Massachusetts, United States | ||
CybSafe | $28M | 06 Jun 2022 | London, England, United Kingdom | ||
Proscia | $36M | 03 Jun 2022 | Philadelphia, Pennsylvania, United States | ||
TrueFort | $30M | 08 Sep 2021 | New Jersey, United States |
– TrueFort announced a $30m Series B round of financing led by Shasta Ventures with the participation of Canaan and existing investors Evolution Equity Partners, Lytical Ventures and Emerald Development Managers.
– As part of the financing round, Nitin Chopra, Managing Director at Shasta Ventures, is joining the company’s board of directors.
– The financing will support hiring across the company, expanded go-to-market activities and multiple R&D initiatives, including offerings that help enterprises better manage their application risk posture.
– Traditional security products have focused on protecting underlying IT infrastructure from threats but the success of attackers in executing ransomware, supply chain and phishing attacks show that there are still significant gaps in security coverage.
– Babson Diagnostics announced a $31m Series B financing round.
– The round was led by Emerald Development Managers with participation from Siemens Healthineers, Prism Ventures, and Lago Consulting Group.
– Babson Diagnostics is a transformative medical technology company improving customer access to diagnostic blood testing.
– Babson intends to use the Series B funding to expand its laboratory and ecosystem infrastructure, finalize its blood testing solution development, and grow its sales and marketing teams.
– Neil Cohen, founder and chairman of Emerald Development Managers, will join the company’s board of directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Proscia | $9M | 11 Jan 2024 | Philadelphia, Pennsylvania, United States | ||
ETCH | $7M | 25 Jul 2023 | Chevy Chase, Maryland, United States | ||
Cyware | $30M | 29 Jun 2023 | New York, New York, United States | ||
Transcend Therapeutics | $40M | 23 Feb 2023 | Waltham, Massachusetts, United States | ||
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
Evolved By Nature | $120M | 28 Jun 2022 | Massachusetts, United States | ||
CybSafe | $28M | 06 Jun 2022 | London, England, United Kingdom | ||
Proscia | $36M | 03 Jun 2022 | Philadelphia, Pennsylvania, United States | ||
TrueFort | $30M | 08 Sep 2021 | New Jersey, United States |
